Abstract:Pyrimidine scaffolds are an exceptional kind of heterocyclic ring that may be used to create and develop novel anticancer drugs. As a result, the current work described the design and synthesis of novel pyrimidine derivatives (5a-j) as potent dual inhibitors of epidermal growth factor receptor (EGFR) and integrating histone deacetylase (HDAC). Using elemental analysis and spectroscopic techniques, the structure of the newly synthesized compounds was elucidated. All the compounds were tested in vitro against MCF-7, HepG2 and A549 cell lines for their antiproliferative properties. Compared to the reference medication erlotinib, compounds 5 h and 5i demonstrated remarkably improved effectiveness against MCF-7, HepG2 and A549 cell lines and better safety towards normal WI-38 cells. The EGFR and HDAC inhibitory effects of compounds 5a, 5c, 5 g, 5 h, and 5i were assessed. With IC 50 values of 8.43 and 6.91 nM, respectively, the compounds 5 h and 5i demonstrated considerable inhibition against EGFR L858R/T790M mutant kinase. Compound 5i had a strong inhibitory effect compared to reference drug Vorinostat (SAHA) against the investigated isoenzymes of HDAC1, HDAC2, HDAC4, and HDAC6 with an IC 50 values of 22.73, 20.08, 3100, and 3.71 nM, respectively. Additionally, docking studies were performed to determine the binding mode of potent compounds 5 h and 5i, towards the potential target EGFR, HDAC1 and HDAC6 proteins. Furthermore, all of these results suggested that the target compounds 5 h and 5i might be seen as viable lead candidates for the dual inhibition of both EGFR and HDAC enzymes, which would enable the identification of novel anticancer agents.

Synthesis, Characterization and Biological Activity of Tetrahydrobenzo[4,5]thieno[2,3-D]pyrimidine Derivatives As Epidermal Growth Factor Receptor Inhibitors

Design, Synthesis, Anti-Tumor Activity, and Molecular Modeling of Quinazoline and Pyrido[2,3-D]Pyrimidine Derivatives Targeting Epidermal Growth Factor Receptor

Synthesis, Characterization, and Biological Activity of a Novel Series of Benzo[4,5]imidazo[2,1-b]thiazole Derivatives as Potential Epidermal Growth Factor Receptor Inhibitors

Design, synthesis, biological evaluation and docking study of novel quinazoline derivatives as EGFR-TK inhibitors

Synthesis, Molecular Docking and Evaluation of Thiazolyl-Pyrazoline Derivatives As Egfr Tk Inhibitors and Potential Anticancer Agents

Discovery of 7-bromo-1,4-dihydrothieno[3’,2’:5,6]thiopyrano[4,3-c]pyrazole-3-carboxamide derivatives as the potential epidermal growth factor receptors for tyrosine kinase inhibitors

Synthesis and Biological Activity of 3,9-Diazatetraasteranes As Novel EGFR Tyrosine Kinase Inhibitors

Design, Synthesis and Biological Evaluation of Novel 6-Alkenylamides Substituted of 4-Anilinothieno[2,3-d]pyrimidines As Irreversible Epidermal Growth Factor Receptor Inhibitors.

Design, synthesis, and biological evaluation of 2-oxo-3,4-dihydropyrimido[4,5-d]pyrimidinyl derivatives as new irreversible epidermal growth factor receptor inhibitors with improved pharmacokinetic properties.

Efficient synthesis and cytotoxic activity of polysubstituted thieno[2,3-d]pyrimidine derivatives

Design, Synthesis, and Biological Evaluation of Pyrimido[4,5- d]pyrimidine-2,4(1 H,3 H)-diones as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance Mutation.

Discovery of thiapyran-pyrimidine derivatives as potential EGFR inhibitors

Synthesis, biological evaluation and molecular docking studies of new pyrimidine derivatives as potent dual EGFR/HDAC inhibitors

Design, synthesis and biological evaluation of aminopyrimidine derivatives bearing a 4,5,6,7-tetrahydrothieno [3,2-c]pyridine as potent EGFR inhibitors

Synthesis, molecular modeling and biological evaluation of 2-(benzylthio)-5-aryloxadiazole derivatives as anti-tumor agents.

Design, synthesis and antitumor activity of novel thiophene-pyrimidine derivatives as EGFR inhibitors overcoming T790M and L858R/T790M mutations

Design, Synthesis and Biological Evaluation of Novel 2,4-Diaryl Pyrimidine Derivatives As Selective EGFRL858R/T790M Inhibitors.

Design, Synthesis and Pharmacological Evaluation of N4,N6-disubstituted Pyrimidine-4,6-diamine Derivatives As Potent EGFR Inhibitors in Non-Small Cell Lung Cancer

Synthesis and Biological Evaluation of 3,9-Dioxatetraasteranes As Potential Inhibitors of Epidermal Growth Factor Receptor

Design, synthesis and antitumor activity of 4-indazolylpyrimidine derivatives as EGFR inhibitors

Discovery of Potent EGFR Inhibitors with 6-Arylureido-4-anilinoquinazoline Derivatives.